IL136046A0 - Methods for classifying proteins - Google Patents

Methods for classifying proteins

Info

Publication number
IL136046A0
IL136046A0 IL13604698A IL13604698A IL136046A0 IL 136046 A0 IL136046 A0 IL 136046A0 IL 13604698 A IL13604698 A IL 13604698A IL 13604698 A IL13604698 A IL 13604698A IL 136046 A0 IL136046 A0 IL 136046A0
Authority
IL
Israel
Prior art keywords
protein
molecules
shift
multiplicity
unfolding curve
Prior art date
Application number
IL13604698A
Other languages
English (en)
Original Assignee
Dimensional Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimensional Pharm Inc filed Critical Dimensional Pharm Inc
Publication of IL136046A0 publication Critical patent/IL136046A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5302—Apparatus specially adapted for immunological test procedures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials Using Thermal Means (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
IL13604698A 1997-11-12 1998-11-12 Methods for classifying proteins IL136046A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6512997P 1997-11-12 1997-11-12
PCT/US1998/024035 WO1999024050A1 (en) 1997-11-12 1998-11-12 High throughput method for functionally classifying proteins identified using a genomics approach

Publications (1)

Publication Number Publication Date
IL136046A0 true IL136046A0 (en) 2001-05-20

Family

ID=22060528

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13604698A IL136046A0 (en) 1997-11-12 1998-11-12 Methods for classifying proteins

Country Status (15)

Country Link
US (2) US20010003648A1 (de)
EP (1) EP1030678B1 (de)
JP (1) JP2002514571A (de)
KR (2) KR20030040425A (de)
AT (1) ATE335498T1 (de)
AU (1) AU750501B2 (de)
CA (1) CA2309345C (de)
DE (1) DE69835531T2 (de)
DK (1) DK1030678T3 (de)
ES (1) ES2273442T3 (de)
HU (1) HU225767B1 (de)
IL (1) IL136046A0 (de)
NZ (1) NZ504483A (de)
PL (1) PL194483B1 (de)
WO (1) WO1999024050A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10509053A (ja) * 1995-09-08 1998-09-08 スクリプトジェン・ファーマスーティカルズ，インコーポレイテッド Ｒｎａに対する親和性を有する化合物のためのスクリーン
PL194483B1 (pl) 1997-11-12 2007-06-29 Dimensional Pharmaceuticals 3 Sposób wyznaczania funkcji biologicznej docelowego białka
US6569631B1 (en) * 1998-11-12 2003-05-27 3-Dimensional Pharmaceuticals, Inc. Microplate thermal shift assay for ligand development using 5-(4″dimethylaminophenyl)-2-(4′-phenyl)oxazole derivative fluorescent dyes
EP1409982A4 (de) * 2001-06-14 2006-05-24 Anadys Pharmaceuticals Inc Verfahren zum screening auf liganden von zielmolekülen
CA2460819A1 (en) * 2001-09-18 2003-03-27 Affinium Pharmaceuticals, Inc. Methods and apparatuses for purification
US20050036536A1 (en) * 2001-09-18 2005-02-17 Lewis Edwin A. High throughout energy array
GB0125436D0 (en) * 2001-10-23 2001-12-12 Deltadot Ltd Analysis of temperature-dependent molecular configurations
AU2003209272A1 (en) * 2002-01-16 2003-09-02 Zyomyx, Inc. Engineered binding proteins
WO2003062458A2 (en) * 2002-01-24 2003-07-31 Ecopia Biosciences Inc. Method, system and knowledge repository for identifying a secondary metabolite from a microorganism
US20040072356A1 (en) * 2002-02-20 2004-04-15 Guillermo Senisterra Methods and apparatuses for characterizing stability of biological molecules
US20050079526A1 (en) * 2002-02-20 2005-04-14 Affinium Pharmaceuticals, Inc. Methods and apparatuses for characterizing refolding and aggregation of biological molecules
WO2003087834A2 (en) * 2002-04-08 2003-10-23 Affinium Pharmaceuticals, Inc. High throughput analysis of recombinant proteins in multi-well plates
US20040121445A1 (en) * 2002-07-31 2004-06-24 Fabien Marino Cell cultures
DE102004017039A1 (de) * 2004-04-02 2005-11-03 Rwth Aachen Verfahren und Vorrichtung zur Erfassung von Prozessparametern von Reaktionsflüssigkeiten in mehreren geschüttelten Mikroreaktoren
US8145433B2 (en) * 2007-10-25 2012-03-27 Canon U.S. Life Sciences, Inc. High-resolution melting analysis
US8993714B2 (en) * 2007-10-26 2015-03-31 Imiplex Llc Streptavidin macromolecular adaptor and complexes thereof
US9102526B2 (en) 2008-08-12 2015-08-11 Imiplex Llc Node polypeptides for nanostructure assembly
WO2010109204A1 (en) * 2009-03-26 2010-09-30 Ucb Pharma S.A. Thermofluor method
WO2010132363A1 (en) 2009-05-11 2010-11-18 Imiplex Llc Method of protein nanostructure fabrication
GB201106548D0 (en) 2011-04-18 2011-06-01 Evitraproteoma Ab A method for determining ligand binding to a target protein using a thermal shift assahy
US9523693B2 (en) 2011-04-18 2016-12-20 Biotarget Engagement Interest Group Ab Methods for determining ligand binding to a target protein using a thermal shift assay
US9366677B2 (en) * 2011-09-06 2016-06-14 Max-Planck-Gesellshaft Zur Foerderung Der Wissenschaften E.V. Methods for analyzing biological macromolecular complexes and use thereof
EP3492921B1 (de) 2012-01-27 2021-05-19 Life Technologies Corporation Zusammensetzungen und kits mit dipyrromethenbor-difluorid-verbindungen
US10024863B2 (en) 2013-03-15 2018-07-17 Life Technologies Corporation Methods for dye selection for protein melt temperature determinations
GB2524519B (en) * 2014-03-25 2019-11-06 Pelago Bioscience AB Methods for identifying a biomarker indicative of a reduced drug response using a thermal shift assay
US11027273B2 (en) * 2015-03-01 2021-06-08 Board Of Regents, The University Of Texas System Apparatuses and methods for pathogen detection using microfluidic biochips
EP3353547A1 (de) * 2015-09-22 2018-08-01 Delta TM Technologies Entwurf von kundenspezifischen proteinspezifischen puffersystemen
US11466309B2 (en) 2018-10-12 2022-10-11 The Board Of Trustees Of The University Of Arkansas Mechanically-strained oligonucleotide constructs and methods of using the same
EP4695590A1 (de) * 2023-04-13 2026-02-18 ThermoCap Laboratories Inc. Gleichzeitige thermische messungen einer vielzahl von proben

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626684A (en) 1983-07-13 1986-12-02 Landa Isaac J Rapid and automatic fluorescence immunoassay analyzer for multiple micro-samples
US4580895A (en) 1983-10-28 1986-04-08 Dynatech Laboratories, Incorporated Sample-scanning photometer
US4628026A (en) 1983-11-15 1986-12-09 Dietlind Gardell Method and apparatus for automated double fluorochromization analysis in lymphocytotoxicity testing
US5096807A (en) 1985-03-06 1992-03-17 Murex Corporation Imaging immunoassay detection system with background compensation and its use
JPS61241639A (ja) 1985-04-19 1986-10-27 Hitachi Ltd 反応試料分析装置
EP0216026B1 (de) 1985-06-26 1992-01-22 Japan Tectron Instruments Corporation Automatischer Analysenapparat
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5260207A (en) * 1987-04-06 1993-11-09 Enzon Labs Inc. Engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins
US4880750A (en) * 1987-07-09 1989-11-14 Miragen, Inc. Individual-specific antibody identification methods
US5133866A (en) 1988-03-24 1992-07-28 Terrapin Technologies, Inc. Method to identify analyte-bending ligands
US5300425A (en) 1987-10-13 1994-04-05 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
US4963263A (en) 1988-03-24 1990-10-16 Terrapin Technologies, Inc. Method of identity analyte-binding peptides
US5338659A (en) 1991-04-02 1994-08-16 Terrapin Technologies, Inc. Method for determining analyte concentration by cross-reactivity profiling
US5217869A (en) 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
US5409611A (en) 1988-03-24 1995-04-25 Terrapin Technoogies, Inc. Method to identify analyte-binding ligands
US5340474A (en) 1988-03-24 1994-08-23 Terrapin Technologies, Inc. Panels of analyte-binding ligands
JP2656564B2 (ja) 1988-08-26 1997-09-24 株式会社日立製作所 免疫分析方法
US5325295A (en) 1989-05-04 1994-06-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Adaptation of microtiter plate technology to measurement of platelet aggregation
WO1992003542A1 (en) 1990-08-17 1992-03-05 Boston University PROTEASES CAUSING ABNORMAL DEGRADATION OF AMYLOID β-PROTEIN PRECURSOR
US5506097A (en) 1990-08-24 1996-04-09 President And Fellows Of Harvard College Method for inhibiting β-protein enzymatic activity
US5200504A (en) 1990-10-02 1993-04-06 The Scripps Research Institute Metallopeptides having stabilized secondary structures
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
DE4123817C2 (de) 1991-07-18 1994-06-09 Berthold Lab Prof Dr Strahlungsmeßgerät, insbesondere zur Messung der Lumineszenz
WO1993014781A1 (en) 1992-01-24 1993-08-05 The Regents Of The University Of California Novel peptides and method for altering the activity of allosteric proteins
EP0592624B1 (de) 1992-03-09 2001-09-19 Accumed International Inc. Diagnostische mikrobiologische testvorrichtung und verfahren
CA2093481A1 (en) 1992-04-30 1993-10-31 Gottlieb Schacher Processing station for carrying out fluorescence polarization measurements in an analyzer
US5255976A (en) 1992-07-10 1993-10-26 Vertex Pharmaceuticals Incorporated Temperature gradient calorimeter
US5314825A (en) 1992-07-16 1994-05-24 Schiapparelli Biosystems, Inc. Chemical analyzer
US5585275A (en) 1992-09-02 1996-12-17 Arris Pharmaceutical Corporation Pilot apparatus for peptide synthesis and screening
US5355215A (en) 1992-09-30 1994-10-11 Environmental Research Institute Of Michigan Method and apparatus for quantitative fluorescence measurements
CA2115900A1 (en) 1993-02-22 1994-08-23 Gerald W. Becker Pharmaceutical screens and antibodies
US5383023A (en) 1993-03-01 1995-01-17 Walleczek; Jan Method and apparatus for performing dual-beam dual-wavelength fluorescence spectrophotometric evaluation of a biological specimen
US5356784A (en) 1993-03-30 1994-10-18 Terrapin Technologies, Inc. Determination of concentration by affinity titration
US5585277A (en) * 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
US5679582A (en) 1993-06-21 1997-10-21 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
JP3598123B2 (ja) 1993-07-15 2004-12-08 浜松ホトニクス株式会社 核酸の変性検出装置
US5436718A (en) 1993-07-30 1995-07-25 Biolumin Corporation Mutli-functional photometer with movable linkage for routing optical fibers
CA2129787A1 (en) 1993-08-27 1995-02-28 Russell G. Higuchi Monitoring multiple amplification reactions simultaneously and analyzing same
US5525300A (en) 1993-10-20 1996-06-11 Stratagene Thermal cycler including a temperature gradient block
US5415839A (en) 1993-10-21 1995-05-16 Abbott Laboratories Apparatus and method for amplifying and detecting target nucleic acids
US5587293A (en) 1994-01-06 1996-12-24 Terrapin Technologies, Inc. Method to identify binding partners
DK1235072T3 (da) 1994-01-06 2007-07-16 Telik Inc Surrogater for målmolekyler og forbedrede referencefelter
US5935803A (en) 1994-02-01 1999-08-10 Terrapin Technologies, Inc. Methods to identify immunomodulators using cognate interaction of PKC-theta
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US5557398A (en) 1994-04-15 1996-09-17 Molecular Devices Corporation Photometric device
US5463564A (en) 1994-09-16 1995-10-31 3-Dimensional Pharmaceuticals, Inc. System and method of automatically generating chemical compounds with desired properties
US5589351A (en) 1994-12-06 1996-12-31 Nps Pharmaceuticals, Inc. Fluorescence detection apparatus
AU5132096A (en) 1995-01-30 1996-08-21 Terrapin Technologies, Inc. Glubodies - multiplicities of proteins capable of binding a variety of small molecules
JPH10509053A (ja) 1995-09-08 1998-09-08 スクリプトジェン・ファーマスーティカルズ，インコーポレイテッド Ｒｎａに対する親和性を有する化合物のためのスクリーン
US5633762A (en) * 1995-10-23 1997-05-27 Motorola Dual image manifestation apparatus with integrated electro-optical package
CA2184195C (en) 1995-10-25 2002-04-16 Andrew Pakula Screening method for identifying ligands for target proteins
JP2000502440A (ja) * 1995-12-07 2000-02-29 スクリプトジェン・ファーマスーティカルズ，インコーポレイテッド リガンドを識別するための蛍光に基づくスクリーニング方法
AU741049B2 (en) 1996-05-09 2001-11-22 Life Technologies Corporation Microplate thermal shift assay and apparatus for ligand development and multi-variable protein chemistry optimization
AU4812097A (en) 1996-10-09 1998-05-05 Symyx Technologies, Inc. Infrared spectroscopy and imaging of libraries
JP2001514511A (ja) 1997-03-05 2001-09-11 スクリプトゲン ファーマシューティカルズ インク 核酸への親和性を持つ化合物同定のための蛍光異方性を用いたスクリーニング
PL194483B1 (pl) 1997-11-12 2007-06-29 Dimensional Pharmaceuticals 3 Sposób wyznaczania funkcji biologicznej docelowego białka
US6376180B1 (en) 1999-12-09 2002-04-23 Pharmacia & Upjohn Company Methods of identifying compounds that bind to target species under isothermal denaturing conditions

Also Published As

Publication number Publication date
EP1030678A4 (de) 2002-10-09
AU750501B2 (en) 2002-07-18
WO1999024050A9 (en) 1999-08-12
PL340449A1 (en) 2001-02-12
DE69835531D1 (de) 2006-09-21
ATE335498T1 (de) 2006-09-15
PL194483B1 (pl) 2007-06-29
HUP0100037A2 (hu) 2001-05-28
KR20030040425A (ko) 2003-05-22
US20020168686A1 (en) 2002-11-14
EP1030678A1 (de) 2000-08-30
CA2309345C (en) 2007-01-23
DK1030678T3 (da) 2006-12-11
WO1999024050A1 (en) 1999-05-20
KR100406310B1 (ko) 2003-11-19
EP1030678B1 (de) 2006-08-09
JP2002514571A (ja) 2002-05-21
US20010003648A1 (en) 2001-06-14
AU1398099A (en) 1999-05-31
HUP0100037A3 (en) 2003-08-28
NZ504483A (en) 2002-11-26
CA2309345A1 (en) 1999-05-20
DE69835531T2 (de) 2007-04-05
KR20010032048A (ko) 2001-04-16
US7122321B2 (en) 2006-10-17
ES2273442T3 (es) 2007-05-01
HU225767B1 (en) 2007-08-28

Similar Documents

Publication Publication Date Title
IL136046A0 (en) Methods for classifying proteins
DK1360500T3 (da) Fremgangsmåde til selektiv målretning
DE69938867D1 (de) Verfahren und verwendung von anordungen von proteinfixierungsmitteln
EP0938571B8 (de) Verfahren zur oligomerisation von peptiden
AU2152299A (en) Multivalent antigen-binding proteins
ATE361364T1 (de) Antikörper gegen die ed-b domäne von fibronektin, ihre herstellung und verwendungen
DE69331903D1 (de) Veränderte Antikörper, damit zusammenhängende Produkte und Verfahren
DK0724456T3 (da) CD40-Antistoffer
WO1996004557A3 (en) Target specific screens and their use for discovering small organic molecular pharmacophores
WO2002002783A3 (en) Expression vectors
WO1999006834A3 (en) Methods for identifying ligand specific binding molecules
DE69638050D1 (de) Hemopoietin-rezeptor und dafür kodierende genetische sequenzen
WO2003029458A3 (de) Verfahren zur herstellung von protein-bibliotheken und zur selektion von proteinen daraus
DE69632333D1 (de) Monoklonaler antikörper br110 und dessen anwendung
ES2158269T3 (es) Un metodo de rastreo para identificar ligandos para proteinas diana.
DK0973806T3 (da) Sted-beskyttet proteinmodificering
DE69628194D1 (de) Verfahren zum nachweis von verbindungen die bestimmte zielmoleküle binden
ATE284409T1 (de) Synthese von sulfurierten oligonukleotiden
WO1997035969A3 (en) Peptide ligands of the urokinase receptor
AU5601896A (en) Ligand growth factors that bind to the erbB-2 receptor protein and induce cellular responses
WO1998016661A3 (en) Morphatides: novel shape and structure libraries
GB9800378D0 (en) Proteome analysis
AU5571998A (en) Chimeric target molecules having a regulatable activity
DK0630968T3 (da) Genetisk selektion af proteiner, som er i stand til ligandbinding, ved hjælp af signaltransduktion i mikroorganismer
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods